Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED-Initiated Standard Versus High Dose Buprenorphine Induction
NCT06494904Phase 3Recruiting
- Sponsor
- Yale University
- Start
- Dec 2024
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of v1003 in opioid use disorder (OUD), sponsored by Yale University. Started Dec 2024; status: recruiting.
02
Drugs
v1003
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06494904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06494904.